1471 QUALITY OF LIFE OUTCOMES AMONGST MEN UNDERGOING CONTEMPORARY TECHNIQUES FOR THE TREATMENT OF LOCALISED PROSTATE CANCER: A PROSPECTIVE STUDY

Abstract

You have accessJournal of UrologyProstate Cancer: Localized VII1 Apr 20121471 QUALITY OF LIFE OUTCOMES AMONGST MEN UNDERGOING CONTEMPORARY TECHNIQUES FOR THE TREATMENT OF LOCALISED PROSTATE CANCER: A PROSPECTIVE STUDY Samarth Chopra, Ruban Thanigasalam, Kieran Beattie, Sam Egger, David Smith, James Symons, Anne-Maree Haynes, Richard Savdie, Phillip Brenner, Rob Sutherland, Krishan Rasiah, and Phillip Stricker Samarth ChopraSamarth Chopra Sydney, Australia More articles by this author , Ruban ThanigasalamRuban Thanigasalam Sydney, Australia More articles by this author , Kieran BeattieKieran Beattie Sydney, Australia More articles by this author , Sam EggerSam Egger Sydney, Australia More articles by this author , David SmithDavid Smith Sydney, Australia More articles by this author , James SymonsJames Symons Sydney, Australia More articles by this author , Anne-Maree HaynesAnne-Maree Haynes Sydney, Australia More articles by this author , Richard SavdieRichard Savdie Sydney, Australia More articles by this author , Phillip BrennerPhillip Brenner Sydney, Australia More articles by this author , Rob SutherlandRob Sutherland Sydney, Australia More articles by this author , Krishan RasiahKrishan Rasiah Sydney, Australia More articles by this author , and Phillip StrickerPhillip Stricker Sydney, Australia More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2012.02.1992AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Monotherapy for localised prostate cancer with radical prostatectomy, external beam radiotherapy or brachytherapy produce similar oncological outcomes. Hence there is increasing need to evaluate and communicate the quality of life outcomes of these treatments. The aim of our prospective study was to determine how the various types of radical treatment at a tertiary referral centre affected the health related quality of life (HRQOL) domains of urinary, sexual, bowel, and hormonal features relative to men managed with active surveillance. METHODS We measured HRQOL outcomes from baseline through to 24 months after treatment using the EPIC questionnaire (Expanded Prostate Cancer Index Composite) in a cohort of 851 patients first treated for stage T1 or T2 prostate cancer from May 2007 to February 2011. Patients elected one of five management options: (1) Robotic prostatectomy (RALP) further subdivided by surgeon experience1 (1a) RALP <200 and (1b) RALP 200+; (2) Radical retropubic prostatectomy (ORP); (3) High dose rate brachytherapy (HDR); (4) Low dose rate brachytherapy (LDR) and (5) active surveillance (AS). Demographic and treatment variables were recorded at baseline. We used multivariate linear regression analyses with generalised estimating equations (GEE) to estimate adjusted mean differences in outcome scores between treatments. RESULTS A total of 770 (96%) men with complete data were included in the analysis. All baseline clinical and demographic characteristics showed significant heterogeneity within treatment types (P<0.001). Questionnaire completion rates ranged from 88% to 100% for any given treatment/month. There was a significant change in sexual quality of life in each group (P<0.005) from baseline to follow-up except in the AS group. Men in the RALP 200+ showed a significant trend towards return to baseline urinary and sexual function. Men in the HDR or LDR brachytherapy groups had worse bowel function and urinary irritation/obstructive scores after treatment but these scores improved between 12-24months. CONCLUSIONS Treatment for localised prostate cancer has significant and persistent adverse effects on quality of life. However, men managed by active surveillance maintained a reasonably stable quality of life scores across all EPIC domains. In the absence of randomized clinical trials, observational studies such as ours can help portray a realistic expectation in terms of changes in quality of life for men treated for localised prostate cancer. © 2012 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 187Issue 4SApril 2012Page: e596-e597 Advertisement Copyright & Permissions© 2012 by American Urological Association Education and Research, Inc.MetricsAuthor Information Samarth Chopra Sydney, Australia More articles by this author Ruban Thanigasalam Sydney, Australia More articles by this author Kieran Beattie Sydney, Australia More articles by this author Sam Egger Sydney, Australia More articles by this author David Smith Sydney, Australia More articles by this author James Symons Sydney, Australia More articles by this author Anne-Maree Haynes Sydney, Australia More articles by this author Richard Savdie Sydney, Australia More articles by this author Phillip Brenner Sydney, Australia More articles by this author Rob Sutherland Sydney, Australia More articles by this author Krishan Rasiah Sydney, Australia More articles by this author Phillip Stricker Sydney, Australia More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...